Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • LLY vs MRNA✓SelectedUSD · MRNALLY vs MRNA performance historyLatest closeAs of-2.29%11/19
Stock and ETF performance explorer

LLY vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+29.5%
MRNA return
+698.9%
Excess return
-669.4%
Maximum drawdown
-23.2%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 1y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-2.3%+1.3%-3.6%-2.3%
7D-5.2%-13.8%+8.6%-4.7%
30D+5.4%-17.7%+23.0%+6.0%
3M+5.7%+14.3%-8.7%+4.7%
6M+32.6%+336.0%-303.3%+19.8%
YTD+26.5%+575.9%-549.4%+9.7%
1Y+29.5%+724.4%-694.9%+10.1%
All+29.5%+698.9%-669.4%+10.1%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 1y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

1y analysis · Full analysis span regression · 6 months rolling